PharmaPoint: Hepatitis C Virus – Current and Future Players

Publisher Name :
Date: 31-May-2013
No. of pages: 64

Summary

GlobalData has released its pharma report, “PharmaPoint: Hepatitis C Virus – Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing HCV Market. The report identifies and analyses the key companies shaping and driving the global HCV market. The report provides insight into the competitive HCV landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalData’s team of industry experts.

Scope

  • Investigation of current and future market competition for HCV
  • Competitor assessment
  • Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
  • Strategic assessment of the HCV sector through market impact analysis, future market scenario and company analysis

Reasons to buy

  • Gain a high level view of the trends shaping and driving the HCV Market
  • Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
  • Create an effective counter-strategy to gain a competitive advantage against those currently in the market
  • What’s the next big thing in the global HCV market landscape? Identify, understand and capitalize

PharmaPoint: Hepatitis C Virus – Current and Future Players

Table Of Contents

1 Table of Contents 5
1.1 List of Tables 7
1.2 List of Figures 8

2 Introduction 9
2.1 Catalyst 9
2.2 Related Reports 9
2.3 Upcoming Related Reports 11

3 Market Outlook 12
3.1 Global Markets 12
3.1.1 Forecast 12
3.1.2 Drivers and Barriers – Global Issues 16

4 Current and Future Players 21
4.1 Overview 21
4.2 Trends in Corporate Strategy 23
4.3 Company Profiles 24
4.3.1 Merck 24
4.3.2 Roche 26
4.3.3 Vertex 28
4.3.4 Janssen 29
4.3.5 Gilead 31
4.3.6 AbbVie 34
4.3.7 Bristol-Myers Squibb 36
4.3.8 Boehringer Ingelheim 38
4.4 Additional Companies with Promising Drugs 40
4.4.1 Mitsubishi Tanabe 40
4.4.2 GlaxoSmithKline 41
4.4.3 Achillion 41
4.4.4 Scynexis 42
4.4.5 Idenix 43
4.4.6 Presidio 44

5 Appendix 45
5.1 Bibliography 45
5.2 Abbreviations 48
5.3 Methodology 49
5.4 Forecasting Methodology 49
5.4.1 Percent Drug-Treated Patients 49
5.4.2 Patient Warehousing 50
5.4.3 Drugs Included in Each Therapeutic Class 50
5.4.4 Launch and Patent Expiry Dates 51
5.4.5 General Pricing Assumptions 52
5.4.6 Individual Drug Assumptions 52
5.4.7 Generic Erosion 55
5.4.8 Selection of Pipeline Agents 55
5.4.9 Pricing of Pipeline Agents 56
5.5 Physicians and Specialists Included in this Study 59
5.6 Survey of Prescribing Physicians 61
5.7 About the Authors 62
5.7.1 Author 62
5.7.2 Epidemiologist 62
5.7.3 Global Head of Healthcare 63
5.8 About GlobalData 64
5.9 Contact Us 64
5.10 Disclaimer 64

List Of Tables

Table 1: Global Sales Forecasts ($m) for HCV, 2012–2022 14
Table 2: HCV Market – Drivers and Barriers, 2013 16
Table 3: Key Companies in the HCV Market, 2012 22
Table 4: Merck’s HCV Portfolio Assessment, 2012 25
Table 5: Merck SWOT Analysis, 2012 25
Table 6: Roche’s HCV Portfolio Assessment, 2012 27
Table 7: Roche SWOT Analysis, 2012 27
Table 8: Vertex’s HCV Portfolio Assessment, 2012 28
Table 9: Vertex SWOT Analysis, 2012 29
Table 10: Janssen’s HCV Portfolio Assessment, 2012 30
Table 11: Janssen SWOT Analysis, 2012 31
Table 12: Gilead’s HCV Portfolio Assessment, 2012 33
Table 13: Gilead SWOT Analysis, 2012 33
Table 14: AbbVie’s HCV Portfolio Assessment, 2012 35
Table 15: AbbVie SWOT Analysis, 2012 35
Table 16: Bristol-Myers Squibb’s HCV Portfolio Assessment, 2012 37
Table 17: Bristol-Myers Squibb SWOT Analysis, 2012 37
Table 18: Boehringer Ingelheim’s HCV Portfolio Assessment, 2012 39
Table 19: Boehringer Ingelheim SWOT Analysis, 2012 39
Table 20: Mitsubishi Tanabe’s HCV Portfolio Assessment, 2012 40
Table 21: GlaxoSmithKline’s HCV Portfolio Assessment, 2012 41
Table 22: Achillion’s HCV Portfolio Assessment, 2012 42
Table 23: Scynexis’ HCV Portfolio Assessment, 2012 42
Table 24: Idenix’s HCV Portfolio Assessment, 2012 43
Table 25: Presidio’s HCV Portfolio Assessment, 2012 44
Table 26: Key Launch Dates 51
Table 27: Key Patent Expiries 51
Table 28: Physicians Surveyed, By Country 61

List of Figures

Figure 1: Global Sales for HCV Therapeutics by Region, 2012–2022 15
Figure 2: Company Portfolio Gap Analysis in HCV, 2012–2022 22

  • Challenges in the Tourism Industry in Thailand
    Thailand has always been a popular tourist destination and tourism provides a major boost to the country’s economy. Bangkok, Hua Hin, Krabi, Samui, Phuket and Cha Am are some of the most attractive tourist destinations in the country. In 2012, Thailand had a very high number of arrivals. Even the number of Thai citizens who [...]
  • Future of the US Consumer Electronics Market
    The market for consumer electronics has been growing steadily. Some of the factors that are contributing to the growth in the market are technological advancement, rise in disposable income and increasing demand for new products. During 2012, consumer electronics market in the US demonstrated positive expansion, although the growth rate slowed down considerably following the [...]
  • Overview of the Global Retail Market
    The global retail industry continued to grow despite the difficult economic conditions in the world. In the fiscal year of 2011, sales-weighted, currency-adjusted revenue rose by 5.1% to $4.271 trillion for the world’s top 250 retailers. According to GRDI (Global Retail Development Index), in 2013 Brazil occupied the top spot in retail development. Chile and [...]
  • Bright Future Predicted for the Tourism Industry in Singapore
    Travel and tourism industry in Singapore has been growing at a steady rate and is considered to be a major contributor to the economic growth of the country. In 2012, Singapore’s IVA (International Visitors Arrivals) reached a record high of 14.5 million, with a growth rate of 10.1% year-on-year. In recent years, inbound travel to [...]
  • Potential of Staffing Market in United States
    The staffing industry places individuals into contract, temporary and permanent positions in firms around the world. Major staffing markets include France, Spain, Italy and Japan as well as many emerging markets. Temporary staffing around the world has been growing, but in US temporary market has been flat since 2006. The majority of staffing revenue majorly [...]
  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Asia-Pacific, Led by China, Drive the Global Methanol Industry
  • China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • Relapsing Multiple Sclerosis (RMS) – Pipeline Review, H2 2014
    Published: 22-Sep-2014        Price: US $2000 Onwards        Pages: 53
    Global Markets Direct's, ‘Relapsing Multiple Sclerosis (RMS) Pipeline Review, H2 2014', provides an overview of the Relapsing Multiple Sclerosis (RMS)'s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Relapsing Multiple Sclerosis (RMS), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and fe......
  • 2014 Market Research Report on Global Diabetes Drugs Industry
    Published: 22-Sep-2014        Price: US $3600 Onwards        Pages: 225
    This is a professional and depth research report on Global Diabetes Drugs industry. The report firstly introduced Diabetes Drugs basic information included Diabetes Drugs definition classification application industry chain structure industry overview; Then introduce North America (United States etc) Europe (France United Kingdom Danmark etc) Asia (China Japan etc) Rest of World Key players 2009-2014 Diabetes Drugs Capacity Production Price Cost Gross Production Value Gross Margin etc Data an......
  • Research Report on China Foot-and-mouth Disease (FMD) Vaccine Industry, 2014-2018
    Published: 17-Sep-2014        Price: US $1800 Onwards        Pages: 50
    China is the world's largest producer and consumer of pork with the output volume accounting nearly 50% of the total. According to the statistics of agricultural production from the National Bureau of Statistics of China, the annual output volume of poultry meat was 83.73 million tons in 2013, up by 1.8% YOY. The output volume of pork was 54.93 million tons, up by 2.8%. The stock volume of hogs was 474.11 million, down by 0.4% compared to 2012. The stock volume of fattened hogs was 715.57 millio......
  • Research Report on China Swine Fever Vaccine Industry, 2014-2018
    Published: 17-Sep-2014        Price: US $1800 Onwards        Pages: 50
    China is the world's largest producer and consumer of pork with the output volume accounting nearly 50% of the total. The output volume of pork was 54.93 million tons in China in 2013, up by 2.8% YOY. The livestock volume of pigs was 474.11 million, down by 0.4% YOY while the stock volume of fattened pigs was 715.57 million, up by 2.5% YOY. Swine fever is considered a highly infectious disease that needs strict prevention, control and extermination. The swine fever vaccine is one of the neces......
  • Research Report on China Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry, 2014-2018
    Published: 17-Sep-2014        Price: US $1800 Onwards        Pages: 50
    China is the world's largest producer and consumer of pork with the output volume of pork accounting for nearly 50% of the total. The output volume of pork was 54.93 million tons in China in 2013, up by 2.8% YOY. The livestock volume of pigs was 474.11 million, down by 0.4% YOY while the stock volume of fattened pigs was 715.57 million, up by 2.5% YOY. The PRRS broke out in southern China and spread rapidly nationwide after summer in 2006, which lead to increases in mortality rate of piglets ......
  • 2014 Deep Research Report on Global and China Diclofenac Industry
    Published: 17-Sep-2014        Price: US $2200 Onwards        Pages: 134
    This is a professional and depth research report on Global and China Diclofenac industry. The report firstly introduced Diclofenac basic information included Diclofenac definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis, Diclofenac industry policy and plan, Diclofenac product specification, manufacturing process, cost structure etc. then statisti......
  • Global Antibiotics Market 2014-2018
    Published: 17-Sep-2014        Price: US $2500 Onwards        Pages: 96
    Antibacterial drugs are chemical compounds used to kill or inhibit the growth of bacteria. The term "antibiotic" is often used synonymously with antibacterial; however, the term "antibiotic" was originally coined to refer to the antibacterial compounds of microbial origin. Antibacterial acts via various mechanisms such as the inhibition of cell wall synthesis, the inhibition of nucleic acid synthesis, the disruption of the cell membrane, and the inhibition of protein synthesis. It can be bacteri......
  • Paliperidone – Patent, Extension and Data Exclusivity Expiry Snapshot (50 countries)
    Published: 16-Sep-2014        Price: US $1400 Onwards        
    Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know. "The most extensive source of patent information available." Product Portfolio Manager - Dr Reddys Laboratories "The database is reliable, frequently updated, well-arranged, user friend......
  • Tolvaptan – Patent, Extension and Data Exclusivity Expiry Snapshot (50 countries)
    Published: 16-Sep-2014        Price: US $1400 Onwards        
    Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know. "The most extensive source of patent information available." Product Portfolio Manager - Dr Reddys Laboratories "The database is reliable, frequently updated, well-arranged, user friend......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs